Robert J. More
Independent DirectorMr. Robert J. More, also known as Bob, MBA, is Director of MBrace Therapeutics, Inc. He is Managing Director of Alta Partners LP. He is Member of Industry Advisory Board of Greenspring Associates, Inc. He is Chief Operating Officer of Morphochem, Inc. He is Director of PatientKeeper, Inc. Since November 2016, Mr. More has served as Managing Director of Alta Partners. He is Director of Carticept Medical, Inc. from October 2005. He joined the Carticept Medical, Inc. in October 2005. He is Director of Cartiva, Inc. He is Director of UC San Diego Sulpizio Cardiovascular Center. He is Director of Affinivax, Inc. He is Independent Director of Sienna Biopharmaceuticals, Inc. from May 2013. He joined the Sienna Biopharmaceuticals, Inc. in May 2013. He served as Venture Capital Advisor of Okapi Venture Capital LLC. He is Independent Director of Vir Biotechnology, Inc. from September 2016. He is Director of Sirenas Marine Discovery LLC from August 2017. He joined the Sirenas Marine Discovery LLC on August 08, 2017. He is Director of Hangzhou Qihan Biotechnology Co., Ltd. He is Director of Variant Bio, Inc. He is Independent Director of Tyra Biosciences, Inc. He was Independent Chairman of the Board of Tyra Biosciences, Inc. from March 2019. He was Independent Director of Tyra Biosciences, Inc. from November 2018. He is Board Member of MBrace Therapeutics, Inc. He is Director of Kelonia Therapeutics, Inc. He was a founding board member of the Kauffman Fellows Program and previously served on the board of BIO (Biotechnology Innovation Organization). He served as Director at IntraLase Corp. He also previously served on the board of directors of the following life sciences companies: Proxima Therapeutics, Inc., Utah Capital Investment Corporation (UCIC), Esprit Pharma, Inc. He also manages the investment in eGenesis. He was Partner of Domain Associates, L.L.C. and was its General Partner since June 1996 until July 2008. He was Head of Venture Investing of Bill & Melinda Gates Foundation. He was Director and investor of Clovis Oncology, Inc. He was General Partner of Frazier Healthcare Partners since September 2008 until June 2013. He focused on Biopharma and Medical Device. He was Director of Achaogen, Inc. He was Director of Glaukos Corporation. He was employed at Glaukos Corporation from January 2001 to June 30, 2015. He managed successful investments in and served on the boards of Affinivax and NovaCardia. He was Director of Neothetics, Inc. He was Executive Officer of Baxter Hemoglobin Therapeutics, Inc. He was Director of Beansprout Networks, Inc. He was Director of Onux Medical, Inc. He was Director of CYTYC Surgical Products II, LLC. He joined the CYTYC Surgical Products II, LLC in 2001. He was Director of OmniSonics Medical Technologies, Inc. He was Director of TargetRx, Inc. He was Senior Sales Associate of Pfizer Health AB. He was Member of the Board of Directors of ESP Pharma, Inc. He was Chairman of Novalar Pharmaceuticals, Inc. He was Secretary of NovaCardia, Inc. He was Director of Auxeris Therapeutics, Inc. He was Director of Receptor BioLogix, Inc. He was Director of Acureon Pharmaceuticals, Inc. He was Director of Apnex Medical, Inc. He was Director of Nuon Therapeutics, Inc. He was Director of Moximed, Inc. He was Director of Oceana Therapeutics, Inc. He was Board Observer of Visterra, Inc. He was Member of Board of Directors of Utah Capital Investment Corp. until 2018. He was employed at Utah Capital Investment Corp. until 2018. Bob was also an investor in Encoded Genomics and Zeltiq Aesthetics. He has B.A. from Middlebury College in 1989, B.S. in Biology from Middlebury College, M.B.A. from Colgate W. Darden Graduate School of Business Administration in 1996.
Positions
- Company NameVir Biotechnology, Inc.Stock CodeVIRPositionIndependent DirectorColleagues
- MDMarianne De BackerPresident, CEO & Director
- VLVicki L. SatoIndependent Chairman
- VDVanina de VerneuilExecutive VP, General Counsel & Corporate Secretary
- LCLawrence CoreyCo-Founder & Scientific Advisor
- LJLouis J. PickerCo-Founder & Scientific Advisor
- ASAziz SawafExecutive VP, CFO & Principal Financial Officer
- RJRobert J. MoreIndependent Director
- Company NameTyra Biosciences, Inc.Stock CodeTYRAPositionIndependent DirectorColleagues
- THTodd HarrisCo-Founder, CEO, President & Director
- BABhavesh AsharChief Operating Officer
- DWDouglas WarnerChief Medical Officer
- DBDaniel BensenCo-Founder & Chief Discovery Officer
- AFAlan FuhrmanChief Financial Officer
- RVRehan VerjeeIndependent Director
- SMSusan MoranIndependent Director
- JSJake SimsonIndependent Director
